Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T19:14:04.724Z.
Calculation as of: 2026-10-06T19:14:04.724Z.
Quote observation: 2026-10-06T19:10:19.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 2cae2ca265fd782e7ea5dc4ad256338ab6ef4494683c6049e605772e3da79ae1
EARNINGS YIELD
N/A
VistaGen Therapeutics, Inc.
Market Cap
$11.22M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.25M
Earnings Yield
N/A
TTM Avg
53.42%
3Y Avg
53.42%
5Y Avg
53.42%
Market Cap
$11.13M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.08M
Earnings Yield
N/A
TTM Avg
44.71%
3Y Avg
44.71%
5Y Avg
44.71%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| VistaGen Therapeutics, Inc. (VTGN) | $11.22M | N/A | N/A | N/A | N/A |
| Lisata Therapeutics, Inc. (LSTA)vs › | $11.25M | N/A | 53.42% | 53.42% | 53.42% |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.13M | N/A | N/A | N/A | N/A |
| Cerenome, Inc. (CNSY)vs › | $11.12M | N/A | N/A | N/A | N/A |
| BioVie Inc. (BIVI)vs › | $11.09M | N/A | N/A | N/A | N/A |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.08M | N/A | 44.71% | 44.71% | 44.71% |
| Phio Pharmaceuticals Corp. (PHIO)vs › | $11.50M | N/A | N/A | N/A | N/A |
| Caring Brands, Inc. (CABR)vs › | $10.82M | N/A | N/A | N/A | N/A |
| Polyrizon Ltd. (PLRZ)vs › | $10.80M | N/A | N/A | N/A | N/A |
| Pluri Inc. (PLUR)vs › | $10.68M | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
